Staging Accuracy in Mycosis Fungoides and Sézary Syndrome Using Integrated Positron Emission Tomography and Computed Tomography
Open Access
- 1 May 2006
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 142 (5) , 577-584
- https://doi.org/10.1001/archderm.142.5.577
Abstract
Research from JAMA Dermatology — Staging Accuracy in Mycosis Fungoides and Sézary Syndrome Using Integrated Positron Emission Tomography and Computed TomographyKeywords
This publication has 21 references indexed in Scilit:
- The Sézary syndrome: hematologic criteriaHematology/Oncology Clinics of North America, 2003
- Assessment of tumor burden and treatment response by 18F-fluorodeoxyglucose injection and positron emission tomography in patients with cutaneous T- and B-cell lymphomasJournal of the American Academy of Dermatology, 2002
- [18F]-FDG positron imaging in clinical management of lymphoma patientsCritical Reviews in Oncology/Hematology, 2001
- Clinical Characteristics and Outcome of Patients With Extracutaneous Mycosis FungoidesJournal of Clinical Oncology, 2001
- The impact of FDG positron emission tomography imaging on the management of lymphomas.The British Journal of Radiology, 2000
- Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality.American Journal of Public Health, 1999
- Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1998
- Computed tomography in the evaluation of cutaneous T-cell lymphomaEuropean Journal of Radiology, 1995
- Cutaneous T-cell lymphoma: CT in evaluation and staging.Radiology, 1993
- Dermatopathic lymphadenopathy and lymph node involvement in mycosis fungoidesCancer, 1980